Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of GTx024 in Women With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines
- Status
- COMPLETED
- Phase
- N/A
A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA)
- Status
- TERMINATED
- Phase
- PHASE2
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
- Status
- COMPLETED
- Phase
- PHASE3
Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3